Clinical Trial Applications: Filter, Search, and view applications


Clear
Extended search...

Page 15 of 39, showing 5 Applications out of 191 total, starting on record 71, ending on 75

# Protocol No Study Title Investigator(s) & Site(s)

71.

ECCT/24/05/03   SIBP-MMR-02
    A Phase III, Multi-Center, Randomized, Observer-Blind, Active Controlled Non-Inferiority Study to Evaluate the Immunogenicity and Safety of Shanghai Institute of Biological Products Co., Ltd.’s Measles, Mumps and Rubella (MMR) Vaccine Compared to a Licensed and WHO Prequalified GSK MMR Vaccine in Healthy African Children, 9- 11 Months of Age   
Principal Investigator(s)
1. Dr Walter Otieno
2. Dr. Diana Odhiambo
Site(s) in Kenya
1. Victoria Biomedical Research Institute (Kisumu county)
2. Victoria Biomedical Research Institute (Kisumu county)
3. Victoria Biomedical Research Institute (Kisumu county)
 
View

72.

ECCT/21/02/03   VAC078
    A Phase III randomized, controlled, multi-centre trial to evaluate the efficacy of the R21/Matrix-M vaccine in African children against clinical malaria.   
Principal Investigator(s)
1. Mainga Patience Mayeso Hamaluba
2. Jean Bosco Ouedraogo
3. Halidou Tinto
4. Alassane Dicko
5. Ally Olotu
Site(s) in Kenya
KEMRI Wellcome Trust Research Programme
 
View

73.

ECCT/24/06/02   ALNASA
    A PHASE III OPEN-LABEL EXTENSION STUDY TO EVALUATE THE LONG-TERM SAFETY OF ASTEGOLIMAB IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE   
Principal Investigator(s)
1. Jesse Gitaka
Site(s) in Kenya
1. Center for Research In Tropical Medicine and Community Development (Nairobi City county)
2. Clinical Research Health Network (CREA-N) (Machakos county)
3. KEMRI-Mtwapa Clinical Annex (Kilifi county)
4. University of Nairobi Clinical Research Centre (Nairobi City county)
5. KEMRI-CRDR Clinical Research Annex (Nairobi City county)
 
View

74.

ECCT/24/08/03   ALNASA
    A PHASE III OPEN-LABEL EXTENSION STUDY TO EVALUATE THE LONG-TERM SAFETY OF ASTEGOLIMAB IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE   
Principal Investigator(s)
1. Mary Inziani Matilu
Site(s) in Kenya
1. KEMRI-Mtwapa Clinical Annex (Kilifi county)
2. Center for Research In Tropical Medicine and Community Development (Nairobi City county)
3. Clinical Research Health Network (CREA-N) (Machakos county)
4. University of Nairobi Clinical Research Centre (Nairobi City county)
5. KEMRI-CRDR Clinical Research Annex (Nairobi City county)
 
View

75.

ECCT/24/09/02   ALNASA
    A PHASE III OPEN-LABEL EXTENSION STUDY TO EVALUATE THE LONG-TERM SAFETY OF ASTEGOLIMAB IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE   
Principal Investigator(s)
1. Teresa Kinyari
Site(s) in Kenya
1. University of Nairobi Clinical Research Centre (Nairobi City county)
2. KEMRI-Mtwapa Clinical Annex (Kilifi county)
3. Center for Research In Tropical Medicine and Community Development (Nairobi City county)
4. Clinical Research Health Network (CREA-N) (Machakos county)
5. KEMRI-CRDR Clinical Research Annex (Nairobi City county)
 
View